
IGM Biosciences Inc
NASDAQ:IGMS

Intrinsic Value
The intrinsic value of one
IGMS
stock under the Base Case scenario is
1.71
USD.
Compared to the current market price of 1.12 USD,
IGM Biosciences Inc
is
Undervalued by 35%.
The Intrinsic Value is calculated as the average of DCF and Relative values:

Valuation History
IGM Biosciences Inc
Fundamental Analysis


Revenue & Expenses Breakdown
IGM Biosciences Inc
Balance Sheet Decomposition
IGM Biosciences Inc
Current Assets | 193.6m |
Cash & Short-Term Investments | 183.8m |
Other Current Assets | 9.8m |
Non-Current Assets | 72.1m |
PP&E | 71m |
Other Non-Current Assets | 1.1m |
Free Cash Flow Analysis
IGM Biosciences Inc
USD | |
Free Cash Flow | USD |
Earnings Waterfall
IGM Biosciences Inc
Revenue
|
2.7m
USD
|
Operating Expenses
|
-196.9m
USD
|
Operating Income
|
-194.2m
USD
|
Other Expenses
|
-1.6m
USD
|
Net Income
|
-195.8m
USD
|
IGMS Profitability Score
Profitability Due Diligence
IGM Biosciences Inc's profitability score is 24/100. The higher the profitability score, the more profitable the company is.

Score
IGM Biosciences Inc's profitability score is 24/100. The higher the profitability score, the more profitable the company is.
IGMS Solvency Score
Solvency Due Diligence
IGM Biosciences Inc's solvency score is 54/100. The higher the solvency score, the more solvent the company is.

Score
IGM Biosciences Inc's solvency score is 54/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
IGMS Price Targets Summary
IGM Biosciences Inc
According to Wall Street analysts, the average 1-year price target for
IGMS
is 1.91 USD
with a low forecast of 0.76 USD and a high forecast of 3.15 USD.
Dividends
Current shareholder yield for IGMS is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one
IGMS
stock under the Base Case scenario is
1.71
USD.
Compared to the current market price of 1.12 USD,
IGM Biosciences Inc
is
Undervalued by 35%.